Archives for February 19, 2014

← 2014

Cytovance to manufacture Pamlico Biopharma antibodies

By Zachary Brennan

CMO Cytovance Biologics has entered into a manufacturing agreement with Pamlico Biopharma to develop a group of three human IgG monoclonal antibodies intended for the treatment of Streptococcus pneumoniae infections.